Licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported license. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.
Nishihara S, Angata K, Aoki-Kinoshita KF, et al., editors. Glycoscience Protocols (GlycoPODv2) [Internet]. Saitama (JP): Japan Consortium for Glycobiology and Glycotechnology; 2021-.
Introduction
Rotaviruses are the major cause of severe gastroenteritis in infants and children in developed and developing countries. Based on their ability to infect host cells treated with sialidase, rotaviruses are classified into two types: sialidase-sensitive strains and sialidase-insensitive strains (1). In the sialidase-insensitive strains, neither infection nor hemagglutination of most human rotaviruses was inhibited by pretreatment of target cells with sialidase from Arthrobacter ureafaciens (2). The mechanism of the feature of carbohydrate residues through which human rotaviruses enter the host cells has been studied (3–5). This protocol was focused on the inhibitory activity of exogenous sialidase-resistant gangliosides GM1a on the infection of host cells by sialidase-insensitive human rotaviruses (KUN and MO strains) (3).
Protocol
The protocol for testing inhibitory activity of GM1a for rotavirus infection of MA104 cells is divided into three steps: 1. preparation of cells, rotaviruses, and gangliosides; 2. pretreatment, viral adsorption, and treatment; and 3. determination of GM1a inhibitory activity by an indirect immunostaining procedure.
Materials
- 1.
Rotaviruses: Human (KUN and MO strains) and feline (FRV64 strain) rotaviruses were propagated in embryonic rhesus monkey kidney cells (MA104 cells) as described previously (3) (Note 1).
- 2.
Gangliosides: Native gangliosides can be isolated from various tissues. Ganglio-series gangliosides, such as GM1a, GM1b, GD1a, GD1b, GT1a, GT1b, and GQ1b are mainly found in and taken from brains of mammals, including bovine, pig, and horse using anion-exchange and iatrobeads column chromatography (3). GA1 was prepared from GM1a.
- 3.
Antibodies: Guinea pig anti-FRV-64 antiserum was prepared as follows: Four weeks-old pathogen-free guinea pigs were immunized with purified feline rotavirus FRV64 strain by intramuscular injection. One month later, the guinea pigs were boosted with a similar intraperitoneal injection. The sera of immunized guinea pigs (anti-FRV64 antisera) were harvested and purified after one week. The antisera crossreacted with human rotaviruses KUN and MO strains (3).
- 4.
Horse radish peroxidase (HRP)-conjugated protein A was purchased from Organon Teknika N.V. Cappel Products.
Instruments
- 1.
Microscopy
- 2.
CO2 incubator
Methods
- 1.
Preparation of cells, rotaviruses, and gangliosides
- a.
MA104 cells were grown in MEM supplemented with 10% fetal bovine serum (FBS) at 37°C in a humidified 95% air, 5% CO2 incubator.
- b.
The viruses were titrated to determine a dilution giving ~200 staining focus-forming units per well of 96-well microtiter tray.
- c.
Exogenous ganglioside GM1a (starting concentration, 50 μM) was serially diluted with PBS (20 mM of phosphate-buffered saline, pH 7.0).
- 2.
Pretreatment, viral adsorption, and treatment
- a.
Mix ganglioside GM1a with an equal volume of trypsin-activated viruses (preincubated with 10 μg/mL of trypsin for 30 min at 37°C) and maintain for 1 h at 37°C.
- b.
Add the ganglioside GM1a/virus mixture to MA104 cells and adsorb for 1 h at 37°C.
- c.
Replace the ganglioside GM1a/virus mixture with the maintenance medium (MEM supplemented with 2% FBS) and leave for 16 h at 37°C. Then, wash the cells with PBS.
- 3.
Determination of GM1a inhibitory activity by an indirect immunostaining procedure (for example data, see Figure 1)
- a.
Fix the infected MA104 cells 80% acetone for 10 min and wash thrice with PBS.
- b.
Incubate the fixed cells with PBS containing anti-FRV64 antiserum at 37°C for 30 min. Then, wash the cells with PBS.
- c.
Incubate the cells with PBS containing HRP-conjugated protein A at 37°C for 30 min and stained with a solution containing 50 mM of Tris buffer (pH 7.5), 0.5 mg/mL of 3.3’-diaminobenzidine tetrahydrochloride, and 0.01% H2O2 aqueous for 20 min at 4°C and wash thrice with PBS.
- d.
Count the stained cells under light microscopy.
Note
- 1.
Rotaviruses should be handled in the facility of Biological Safety Level 2 under the control of national law (6).
References
- 1.
- Mendez E, Arias C.F, and Lopez S.A. Interactions between the two surface proteins of rotavirus may alter the receptor binding specificity of the virus. J Virol. 1996 Feb;70(2):1218-22. doi: 10.1128/JVI.70.2.1218-1222.1996.PMID: 8551583. [PMC free article: PMC189931] [PubMed: 8551583] [CrossRef]
- 2.
- Yolken RH, Willoughby R, Wee SB, Miskuff R, Vonderfecht S. Sialic acid glycoprotein inhibits in vitro and in vivo replication of rotavirus. J Clin Invest. 1987 Jan;79(1):148–54. [PMC free article: PMC424010] [PubMed: 3025257] [CrossRef]
- 3.
- Guo Chao-Tan, Nakagomi O, Mochizuki M, Ishida H, Kiso M, Ohta Y, Suzuki T, Miyamoto D, Hidari KI, Suzuki Y. Ganglioside GM1a on the cell surface is involved in the infection by human rotavirus KUN and MO strains. J Biochem. 1999 Oct;126(4):683–8. [PubMed: 10502675] [CrossRef]
- 4.
- Haselhorst T, Fleming FE, Dyason JD, Hartnell RD, Yu X, Holloway G, Santegoets K, Kiefel MJ, Blanchard H, Coulson BS, von Itzstein M. Sialic acid depencence in rotavirus host cell invasion. Nat Chem Biol. 2009 Feb;5(2):91–3. [PubMed: 19109595] [CrossRef]
- 5.
- Banda K, Kang G, Varki A. Sialidase sensitivity of rotaviruses revisited. Nat Chem Biol. 2009 Feb;5(2):71–2. [PubMed: 19148170] [CrossRef]
- 6.
Footnotes
The authors declare no competing or financial interests.
Figures

Figure 1:
Inhibitory activity of exogenous ganglioside GM1a on the infection of MA104 cells by rotaviruses.
The inhibitory activity of GM1a (closed) and GA1 (asialo GM1) (open), which are used as controls for the infections KUN (triangle), MO (inverted triangle), and FRV64 (circle) strains of MA104 cells, was determined using a neutralization assay as described above.